Eisai Inc.
Clinical trials sponsored by Eisai Inc., explained in plain language.
-
New drug targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study tests an experimental drug called MORAb-202 that delivers chemotherapy directly to cancer cells with a specific marker (FRα). It is for people with ovarian, endometrial, lung, or triple-negative breast cancer that has spread. The goal is to find the safest and most eff…
Phase: PHASE1, PHASE2 • Sponsor: Eisai Inc. • Aim: Disease control
Last updated May 16, 2026 23:46 UTC
-
New hope for kids with epilepsy: add-on drug shows promise in reducing seizures
Disease control Recruiting nowThis study is testing an add-on medication called perampanel to see if it can reduce seizures in children aged 1 month to 18 years with epilepsy. The main goal is to find out how many children have at least half fewer seizures while taking the drug. The study is open-label, meani…
Phase: PHASE2 • Sponsor: Eisai Inc. • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New malaria pill takes first step: is it safe for humans?
Knowledge-focused Recruiting nowThis early-stage study tests a new oral drug called E1018 in 32 healthy adults to see if it is safe and how the body processes it. Participants receive a single dose and are monitored for side effects and drug levels in blood and urine. This study does not aim to treat or prevent…
Phase: PHASE1 • Sponsor: Eisai Inc. • Aim: Knowledge-focused
Last updated May 16, 2026 23:48 UTC
-
Healthy men needed to track how drug E2086 leaves the body
Knowledge-focused Recruiting nowThis study looks at how healthy men absorb, break down, and get rid of a drug called E2086. Ten participants will receive a single dose with a radioactive tracer to track the drug in blood, urine, and stool. The goal is to understand the drug's metabolism and excretion, not to tr…
Phase: PHASE1 • Sponsor: Eisai Inc. • Aim: Knowledge-focused
Last updated May 16, 2026 23:36 UTC